Emerson Electric Co. (EMR) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$147.92
Price Target
$161.92
Target Range
$125.00 — $185.00
Analyst Rating
Buy
Forward P/E22.8x
Trailing P/E36.6x
Forward PEG5.04
Implied Growth+49.6%
Median Target$168.00
Analyst Spread37.1%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$125
-15.5%
Consensus
$162
+9.5%
Bull Case
$185
+25.1%
Valuation Model TargetsConfidence: 65/100
Bear$291
Base$249
Bull$543
EMR Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Emerson Electric Co. (EMR) has a Wall Street consensus price target of $161.92, based on estimates from 41 covering analysts. With the stock currently trading at $147.92, this represents a potential upside of +9.5%. The company has a market capitalization of $83.18B.
Analyst price targets range from a low of $125.00 to a high of $185.00, representing a 37% spread in expectations. The median target of $168.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 21 analysts rating the stock as a Buy or Strong Buy,17 rating it Hold, and 3 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, EMR trades at a trailing P/E of 36.6x and forward P/E of 22.8x. The forward PEG ratio of 5.04 reflects a premium valuation. Analysts expect EPS to grow +49.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $249.45, with bear and bull scenarios of $291.44 and $542.80 respectively. Model confidence stands at 65/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Industrials stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+7.4%
Avg Forward P/E27.7x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HONHoneywell International Inc. | $137.4B | $216.82 | $243.83 | +12.5% | Buy | 20.6x | 28 |
 ROKRockwell Automation, Inc. | $51.6B | $459.35 | $436.56 | -5.0% | Hold | 37.8x | 39 |
 ETNEaton Corporation plc | $163.5B | $421.39 | $379.78 | -9.9% | Buy | 31.7x | 39 |
 AMEAMETEK, Inc. | $55.3B | $241.38 | $245.91 | +1.9% | Buy | 29.9x | 29 |
 PNRPentair plc | $12.9B | $79.97 | $113.56 | +42.0% | Hold | 14.9x | 41 |
 FELEFranklin Electric Co., Inc. | $4.5B | $100.98 | $100.00 | -1.0% | Hold | 22.0x | 11 |
 RBCRBC Bearings Incorporated | $20.4B | $623.13 | $572.60 | -8.1% | Buy | 51.3x | 26 |
 NDSNNordson Corporation | $16.0B | $286.94 | $311.50 | +8.6% | Buy | 25.1x | 20 |
 IEXIDEX Corporation | $16.2B | $218.19 | $242.14 | +11.0% | Hold | 25.9x | 29 |
 FLSFlowserve Corporation | $9.4B | $73.38 | $89.57 | +22.1% | Hold | 17.9x | 31 |
Upside Potential Comparison
PNRFLSHONIEXNDSNAMEFELEROKFull EMR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See EMR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EMR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EMR vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonEMR — Frequently Asked Questions
Quick answers to the most common questions about buying EMR stock.
What is the EMR stock price target for 2026?
The consensus price target for EMR is $161.92, close to the current price of $147.92 (9.5% implied move). Based on 41 analyst estimates, the stock appears fairly valued near current levels.
Is EMR a buy, sell, or hold?
EMR has a consensus rating of "Buy" based on 41 Wall Street analysts. The rating breakdown is predominantly bullish, with 21 Buy/Strong Buy ratings. The consensus 12-month price target of $161.92 implies 9.5% upside from current levels.
Is EMR stock overvalued or undervalued?
EMR trades at a forward P/E of 22.7657x, representing a moderate valuation. With analysts targeting $161.92 (9.5% implied move), the stock appears reasonably valued with upside.
How high can EMR stock go?
The most bullish Wall Street analyst has a price target of $185 for EMR, while the most conservative target is $125. The consensus of $161.92 represents the median expectation. Our quantitative valuation model projects a bull case target of $543 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover EMR stock?
EMR is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 21 have Buy ratings, 17 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the EMR stock forecast?
The 12-month EMR stock forecast based on 41 Wall Street analysts shows a consensus price target of $161.92, with estimates ranging from $125 (bear case) to $185 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $249, with bear/bull scenarios of $291/$543.
What is EMR's fair value based on fundamentals?
Our quantitative valuation model calculates EMR's fair value at $249 (base case), with a bear case of $291 and bull case of $543. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 65/100.
What is EMR's forward P/E ratio?
EMR trades at a forward P/E ratio of 22.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 36.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy EMR stock?
EMR appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $161.92 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do EMR price targets vary so much?
EMR analyst price targets range from $125 to $185, a 37% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $161.92 consensus represents the middle ground. Our model's $291-$543 range provides an independent fundamental perspective.